Circulating endothelial cells as a novel marker of angiogenesis

Patrizia Mancuso, Angelica Calleri, Cristina Cassi, Alberto Gobbi, Manuela Capillo, Giancarlo Pruneri, Giovanni Martinelli, Francesco Bertolini

Research output: Contribution to journalArticle

Abstract

Measurement of tumor angiogenesis to predict and/or to assess the efficacy of antiangiogenic therapies is mainly based on the evaluation of microvessel density (MVD). We developed a novel flow cytometry procedure to measure circulating endothelial cells (CECs) and circulating endothelial cells progenitors (CECPs) in either preclinical and clinical studies. Preclinical studies were performed on an animal model of human lymphoma. A trend toward higher CECs values was observed on day 7 and 14 after transplant, and differences vs controls were highly significant on day 21 (p=0.0061). A strong correlation was found between CECs and tumor volume (r=0.942, p=0.004) and between CECs and tumor-generated VEGF (r=0.669, p=0.02). In mice given cyclophosphamide, most of circulating apoptotic cells were hematopoietic and not endothelial. Conversely, in mice given endostatin, all of the increase in apoptotic cells was in the endothelial cell compartment. In a parallel study, we looked for CECs in the peripheral blood of 20 healthy controls and 76 newly diagnosed cancer patients by means of four-color flow cytometry. In breast cancer (n=46) and lymphoma (n=30) patients, both resting and activated CECs were increased by 5 fold (P

Original languageEnglish
Pages (from-to)83-97
Number of pages15
JournalAdvances in Experimental Medicine and Biology
Volume522
Publication statusPublished - 2003

Fingerprint

Endothelial cells
Endothelial Cells
Tumors
Flow cytometry
Lymphoma
Flow Cytometry
Endostatins
Circulating Neoplastic Cells
Cells
Transplants
Microvessels
Tumor Burden
Cell Size
Cyclophosphamide
Vascular Endothelial Growth Factor A
Neoplasms
Animal Models
Color
Animals
Blood

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Circulating endothelial cells as a novel marker of angiogenesis. / Mancuso, Patrizia; Calleri, Angelica; Cassi, Cristina; Gobbi, Alberto; Capillo, Manuela; Pruneri, Giancarlo; Martinelli, Giovanni; Bertolini, Francesco.

In: Advances in Experimental Medicine and Biology, Vol. 522, 2003, p. 83-97.

Research output: Contribution to journalArticle

@article{f90fa4f77bb449dc8991150f4a7fe126,
title = "Circulating endothelial cells as a novel marker of angiogenesis",
abstract = "Measurement of tumor angiogenesis to predict and/or to assess the efficacy of antiangiogenic therapies is mainly based on the evaluation of microvessel density (MVD). We developed a novel flow cytometry procedure to measure circulating endothelial cells (CECs) and circulating endothelial cells progenitors (CECPs) in either preclinical and clinical studies. Preclinical studies were performed on an animal model of human lymphoma. A trend toward higher CECs values was observed on day 7 and 14 after transplant, and differences vs controls were highly significant on day 21 (p=0.0061). A strong correlation was found between CECs and tumor volume (r=0.942, p=0.004) and between CECs and tumor-generated VEGF (r=0.669, p=0.02). In mice given cyclophosphamide, most of circulating apoptotic cells were hematopoietic and not endothelial. Conversely, in mice given endostatin, all of the increase in apoptotic cells was in the endothelial cell compartment. In a parallel study, we looked for CECs in the peripheral blood of 20 healthy controls and 76 newly diagnosed cancer patients by means of four-color flow cytometry. In breast cancer (n=46) and lymphoma (n=30) patients, both resting and activated CECs were increased by 5 fold (P",
author = "Patrizia Mancuso and Angelica Calleri and Cristina Cassi and Alberto Gobbi and Manuela Capillo and Giancarlo Pruneri and Giovanni Martinelli and Francesco Bertolini",
year = "2003",
language = "English",
volume = "522",
pages = "83--97",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Circulating endothelial cells as a novel marker of angiogenesis

AU - Mancuso, Patrizia

AU - Calleri, Angelica

AU - Cassi, Cristina

AU - Gobbi, Alberto

AU - Capillo, Manuela

AU - Pruneri, Giancarlo

AU - Martinelli, Giovanni

AU - Bertolini, Francesco

PY - 2003

Y1 - 2003

N2 - Measurement of tumor angiogenesis to predict and/or to assess the efficacy of antiangiogenic therapies is mainly based on the evaluation of microvessel density (MVD). We developed a novel flow cytometry procedure to measure circulating endothelial cells (CECs) and circulating endothelial cells progenitors (CECPs) in either preclinical and clinical studies. Preclinical studies were performed on an animal model of human lymphoma. A trend toward higher CECs values was observed on day 7 and 14 after transplant, and differences vs controls were highly significant on day 21 (p=0.0061). A strong correlation was found between CECs and tumor volume (r=0.942, p=0.004) and between CECs and tumor-generated VEGF (r=0.669, p=0.02). In mice given cyclophosphamide, most of circulating apoptotic cells were hematopoietic and not endothelial. Conversely, in mice given endostatin, all of the increase in apoptotic cells was in the endothelial cell compartment. In a parallel study, we looked for CECs in the peripheral blood of 20 healthy controls and 76 newly diagnosed cancer patients by means of four-color flow cytometry. In breast cancer (n=46) and lymphoma (n=30) patients, both resting and activated CECs were increased by 5 fold (P

AB - Measurement of tumor angiogenesis to predict and/or to assess the efficacy of antiangiogenic therapies is mainly based on the evaluation of microvessel density (MVD). We developed a novel flow cytometry procedure to measure circulating endothelial cells (CECs) and circulating endothelial cells progenitors (CECPs) in either preclinical and clinical studies. Preclinical studies were performed on an animal model of human lymphoma. A trend toward higher CECs values was observed on day 7 and 14 after transplant, and differences vs controls were highly significant on day 21 (p=0.0061). A strong correlation was found between CECs and tumor volume (r=0.942, p=0.004) and between CECs and tumor-generated VEGF (r=0.669, p=0.02). In mice given cyclophosphamide, most of circulating apoptotic cells were hematopoietic and not endothelial. Conversely, in mice given endostatin, all of the increase in apoptotic cells was in the endothelial cell compartment. In a parallel study, we looked for CECs in the peripheral blood of 20 healthy controls and 76 newly diagnosed cancer patients by means of four-color flow cytometry. In breast cancer (n=46) and lymphoma (n=30) patients, both resting and activated CECs were increased by 5 fold (P

UR - http://www.scopus.com/inward/record.url?scp=0038367708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038367708&partnerID=8YFLogxK

M3 - Article

C2 - 12674213

AN - SCOPUS:0038367708

VL - 522

SP - 83

EP - 97

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -